Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.02
-0.19 (-5.92%)
At close: Aug 15, 2025, 12:39 PM

Bionano Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.46M 8.16M 6.07M 7.77M 8.77M 10.72M 9.32M 8.66M 7.42M 8.21M 7.22M 6.67M 5.7M 6.3M 4.66M 3.86M 3.17M
Cost of Revenue
3.05M 4.75M 14.52M 5.19M 5.95M 8.28M 6.57M 6.35M 5.34M 6.41M 5.41M 5.2M 4.83M 6.06M 3.5M 2.42M 2.13M
Gross Profit
3.4M 3.42M -8.45M 2.58M 2.82M 2.44M 2.75M 2.31M 2.07M 1.8M 1.81M 1.47M 861K 239K 1.15M 1.44M 1.04M
Operating Income
-8.46M -11.94M -43.9M -17.02M -27.13M -20.03M -113.21M -39.24M -37.84M -37.53M -32.15M -32.08M -29.94M -28.78M -20.68M -16.48M -11.16M
Interest Income
290K 225K 376K 457K 1.04M 1.19M 730K 689K 704K 770K 436K 192K 110K 236K 29K 58K 65K
Pretax Income
-3.1M -20.12M -44.22M -16.2M -31.44M -43.93M -112.53M -38.88M -37.1M -36.87M -31.78M -32.12M -29.94M -28.72M -20.72M -18.78M -9.94M
Net Income
-3.1M -20.13M -44.25M -16.22M -31.42M -43.89M -112.57M -38.91M -37.12M -38.68M -31.81M -32.16M -29.95M -22.95M -20.75M -18.79M -9.95M
Selling & General & Admin
9.03M 11.75M 9.46M 11.56M 20.18M 10.77M 24.9M 26.94M 25.98M 25.32M 21.22M 21.78M 20.28M 19.81M 15.33M 13.83M 9.53M
Research & Development
2.37M 3.47M 4.72M 6.83M 9.78M 11.7M 13.79M 14.61M 13.94M 14.01M 12.74M 11.77M 10.53M 9.21M 6.5M 4.09M 2.68M
Other Expenses
n/a 138K 21.27M 1.22M n/a n/a 26K -256K n/a -40K 5K -156K -33K 37K -67K -15K -15K
Operating Expenses
11.4M 15.36M 35.45M 19.6M 29.95M 22.47M 38.68M 41.55M 39.91M 39.33M 33.96M 33.55M 30.8M 29.02M 21.83M 17.91M 12.21M
Interest Expense
85K 27K 68K n/a 122K 4.9M 71K 74K 76K 75K 73K 74K 77K 206K 2K 268K 603K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.46M 20.1M 49.97M 24.79M 35.9M 30.75M 45.25M 47.9M 45.26M 45.74M 39.37M 38.75M 35.64M 35.09M 25.33M 20.33M 14.33M
Income Tax Expense
-7K 1K 24K 26K -18K -36K 39K 33K 26K 1.8M 28K 41K 9K -5.77M 35K 9K 6K
Shares Outstanding (Basic)
2.69M 1.9M 1.46M 1.15M 890.29K 676.6K 595.02K 535.47K 513.1K 504.82K 492.49K 485.44K 483.84K 482.72K 476.3K 456.23K 448.7K
Shares Outstanding (Diluted)
2.69M 1.9M 1.46M 1.15M 896.56K 677.66K 595.02K 535.47K 513.49K 504.82K 492.49K 485.44K 483.84K 482.72K 476.3K 474.13K 448.7K
EPS (Basic)
-1.15 -647.4 -1.8K -864 -2.15K -3.96K -11.58K -4.45K -4.42K -4.69K -3.95K -4.05K -3.79K -2.91K -2.67K -2.42K -1.36K
EPS (Diluted)
-1.15 -647.4 -1.8K -864 -2.16K -3.97K -11.58K -4.45K -4.43K -4.69K -3.95K -4.05K -3.79K -2.91K -2.67K -2.52K -1.36K
EBITDA
-8.46M -17.65M -38.47M -12.71M -28.26M -35.43M -108.83M -35.6M -33.78M -33.94M -29.28M -29.74M -27.63M -26.03M -20.19M -18.05M -8.96M
EBIT
n/a -20.1M -44.15M -15.8M -31.32M -39.03M -112.46M -38.8M -37.02M -36.8M -31.71M -32.04M -29.87M -28.91M -20.72M -18.57M -9.4M
Depreciation & Amortization
n/a 2.45M 5.68M 3.04M 3.06M 3.6M 3.63M 3.2M 3.24M 2.86M 2.43M 2.3M 2.51M 2.48M 526K 516K 448K